Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice

Kuniaki Saito, Sanford P. Markey, Melvyn P. Heyes

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Chronic infections are associated with increased concentrations of the neuroactive kynurenine pathway metabolite, quinolinic acid (QUIN), in blood and cerebrospinal fluid. In the present study, repeated injections of γ-interferon (5000 IU, every 3 days for 39 days) to C57BL6 mice were associated with persistent activation of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, in lung and brain, sustained increases in brain QUIN concentration and increases in plasma l-kynurenine and QUIN levels. Mice chronically treated with γ-interferon offer an animal model to investigate the effects of sustained immune stimulation on kynurenine pathway metabolism.

Original languageEnglish
Pages (from-to)151-154
Number of pages4
JournalBrain Research
Volume546
Issue number1
DOIs
Publication statusPublished - 12-04-1991
Externally publishedYes

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Quinolinic Acid
Kynurenine
Interferons
Brain
Cerebrospinal Fluid
Animal Models
Lung
Injections
Enzymes
Infection

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

@article{32f3488fd48147e5950167aab36c9e9c,
title = "Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice",
abstract = "Chronic infections are associated with increased concentrations of the neuroactive kynurenine pathway metabolite, quinolinic acid (QUIN), in blood and cerebrospinal fluid. In the present study, repeated injections of γ-interferon (5000 IU, every 3 days for 39 days) to C57BL6 mice were associated with persistent activation of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, in lung and brain, sustained increases in brain QUIN concentration and increases in plasma l-kynurenine and QUIN levels. Mice chronically treated with γ-interferon offer an animal model to investigate the effects of sustained immune stimulation on kynurenine pathway metabolism.",
author = "Kuniaki Saito and Markey, {Sanford P.} and Heyes, {Melvyn P.}",
year = "1991",
month = "4",
day = "12",
doi = "10.1016/0006-8993(91)91171-V",
language = "English",
volume = "546",
pages = "151--154",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. / Saito, Kuniaki; Markey, Sanford P.; Heyes, Melvyn P.

In: Brain Research, Vol. 546, No. 1, 12.04.1991, p. 151-154.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice

AU - Saito, Kuniaki

AU - Markey, Sanford P.

AU - Heyes, Melvyn P.

PY - 1991/4/12

Y1 - 1991/4/12

N2 - Chronic infections are associated with increased concentrations of the neuroactive kynurenine pathway metabolite, quinolinic acid (QUIN), in blood and cerebrospinal fluid. In the present study, repeated injections of γ-interferon (5000 IU, every 3 days for 39 days) to C57BL6 mice were associated with persistent activation of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, in lung and brain, sustained increases in brain QUIN concentration and increases in plasma l-kynurenine and QUIN levels. Mice chronically treated with γ-interferon offer an animal model to investigate the effects of sustained immune stimulation on kynurenine pathway metabolism.

AB - Chronic infections are associated with increased concentrations of the neuroactive kynurenine pathway metabolite, quinolinic acid (QUIN), in blood and cerebrospinal fluid. In the present study, repeated injections of γ-interferon (5000 IU, every 3 days for 39 days) to C57BL6 mice were associated with persistent activation of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, in lung and brain, sustained increases in brain QUIN concentration and increases in plasma l-kynurenine and QUIN levels. Mice chronically treated with γ-interferon offer an animal model to investigate the effects of sustained immune stimulation on kynurenine pathway metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0025728920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025728920&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(91)91171-V

DO - 10.1016/0006-8993(91)91171-V

M3 - Article

C2 - 1830237

AN - SCOPUS:0025728920

VL - 546

SP - 151

EP - 154

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -